Asantae to Present at the 4th Annual LD MICRO Growth Conference
December 01 2011 - 5:01AM
Marketwired
Asantae Holdings International Inc. (TSX-V: JVA), a leading
producer and marketer of innovative nutritional products through
direct and network marketing channels, today announced that it has
been invited to present at the 4th Annual LD MICRO Growth
Conference, held December 7-8 at the Luxe Sunset Bel Air Hotel, Los
Angeles.
Asantae's COO, Daniel Lundell, will present on Wednesday,
December 7, 2011 at 4pm PST, with availability for one-on-one
meetings throughout the day on December 8.
Mr. Lundell will discuss Asantae's growth strategy with a focus
on the company's successful pre-launch of RealW8™, its
revolutionary weight loss product that is changing the way the
world looks at obesity and weight loss.
The LD MICRO conference brings together 101 presenting companies
with more than 150 institutions focused on investing in small and
micro cap companies across multiple industries.
Neither the TSX Venture Exchange nor its
Regulation Services Provider (as that term is defined in the
policies of the TSX Venture Exchange) accepts responsibility for
the adequacy or accuracy of this release.
About LD Micro
LD MICRO is a by-invitation only newsletter firm that focuses on
finding undervalued companies in the micro-cap space. Since 2002,
the firm has published an annual list of recommended stocks as well
as comprehensive reports on select companies throughout the year.
LD MICRO concentrates on finding, researching, and investing in
companies that are overlooked by institutional investors. It is a
non-registered investment advisor. To register, please call
408-457-1042 or visit www.ldmicro.com.
About Asantae
Asantae Holdings International Inc. (www.asantae.com) (TSX-V:
JVA) is a producer and marketer of innovative nutritional products
through direct and network marketing channels. The ingredients in
Asantae's products have been shown to reduce chronic low-grade
inflammation and oxidative stresses which, according to scientific
and medical research, are the underlying conditions for most modern
epidemic diseases (diabetes, heart disease, obesity, stroke,
etc.).
Forward Looking Statements
Certain information in this news release is forward-looking
within the meaning of certain securities laws, and is subject to
important risks, uncertainties and assumptions. This
forward-looking information includes, among other things,
information with respect to the Company's beliefs, plans,
expectations, anticipations, estimates and intentions, including
the listing and trading of the Company's common shares on the
Exchange. The words "may", "could", "should", "would", "suspect",
"outlook", "believe", "anticipate", "estimate", "expect", "intend",
"plan", "target" and similar words and expressions are used to
identify forward-looking information. The forward-looking
information in this news release describes the Company's
expectations as of the date of this news release.
The results or events anticipated or predicted in such
forward-looking information may differ materially from actual
results or events. Material factors which could cause actual
results or events to differ materially from such forward-looking
information include, among others, the Company's ability to develop
new products which will receive market acceptance, to receive
market acceptance in new markets outside the United States, to
engage and retain qualified key personnel, employees and
affiliates, to obtain capital and credit and to protect its
intellectual property rights.
The Company cautions that the foregoing list of material factors
is not exhaustive. When relying on the Company's forward-looking
information to make decisions, investors and others should
carefully consider the foregoing factors and other uncertainties
and potential events. The Company has assumed a certain
progression, which may not be realized. It has also assumed that
the material factors referred to in the previous paragraph will not
cause such forward-looking information to differ materially from
actual results or events. However, the list of these factors is not
exhaustive and is subject to change and there can be no assurance
that such assumptions will reflect the actual outcome of such items
or factors.
THE FORWARD-LOOKING INFORMATION CONTAINED IN THIS NEWS RELEASE
REPRESENTS THE EXPECTATIONS OF THE COMPANY AS OF THE DATE OF THIS
NEWS RELEASE AND, ACCORDINGLY, IS SUBJECT TO CHANGE AFTER SUCH
DATE. READERS SHOULD NOT PLACE UNDUE IMPORTANCE ON FORWARD-LOOKING
INFORMATION AND SHOULD NOT RELY UPON THIS INFORMATION AS OF ANY
OTHER DATE. WHILE THE COMPANY MAY ELECT TO, IT DOES NOT UNDERTAKE
TO UPDATE THIS INFORMATION AT ANY PARTICULAR TIME.
For further information respecting the Company please contact:
Daniel Lundell CFO/COO 10153 E Hampton Ave, Ste 101 Mesa,
Arizona, 85209 USA Phone: 480-278-8712 Fax: 480-383-6147
Avidus Management Group, Inc. (TSXV:JVA)
Historical Stock Chart
From Sep 2024 to Oct 2024
Avidus Management Group, Inc. (TSXV:JVA)
Historical Stock Chart
From Oct 2023 to Oct 2024